AP, John Amis Walmart is once again undercutting Apple (AAPL) on its own phone, slashing the price of the new iPhone 5c to $45 -- less than half the $99 suggested retail price. The iPhone 5s and 5c came out on Sept. 20, and at the time Walmart (WMT) surprised everyone by selling the phones at below-market prices of $189 and $79, respectively. Now, just two weeks after that launch, the price on the downmarket 5c is coming down even more. The move appears to come in response to rival Best Buy (BBY), which on Thursday announced that it was taking the price of the phone down to $50. In a statement, Walmart spokesperson Sarah McKinney said that "providing our customers low prices on the newest technology is what we do." She did, however, acknowledge Best Buy's own price cut, and said that "As a price leader, we are always looking for ways to surprise our customers with low prices and disrupt the competition." Besides beating Best Buy's price by $5, Walmart has another advantage: Its pricing is good at least through the end of the holiday season, while Best Buy's pricing is only good through Oct. 7. Walmart also has an active trade-in program that lets you apply the value of your old phone to your purchase. Walmart isn't the only retailer responding to Best Buy's big price cut: RadioShack (RSH) also announced Friday that it will discount the phone to $50, a price that will be good through Nov. 2. Still, with so many retailers suddenly discounting the 5c, we wouldn't be surprised if it became the standard pricing for the phone going forward. Regardless, one thing is clear: For now, the Apple Store is not the best place to buy this iPhone. Stop texting and start saving! Yes, your smartphone can save you money – from coupons to comparing prices to making a shopping list, these seven smartphone apps are the key to making sure you don’t go over your budget. And they’re all free!
Top China Companies To Own For 2015: Brookdale Senior Living Inc. (BKD)
Brookdale Senior Living Inc. owns and operates senior living communities in the United States. It operates in six segments: Retirement Centers, Assisted Living, Continuing Care Retirement Communities (CCRCs)�Rental, CCRCs-Entry Fee, Innovative Senior Care, and Management Services. The Retirement Centers segment owns or leases communities comprising independent living and assisted living units in a single community that are primarily designed for middle to upper income senior citizens. The Assisted Living segment owns or leases communities consisting of freestanding, multi-story communities, and freestanding single story communities, which offer housing and 24-hour assistance to mid-acuity frail and elderly residents. This segment also operates memory care communities for residents with Alzheimer's disease and other dementias. The CCRCs-Rental segment owns or leases communities that offer various living arrangements and services to accommodate physical ability and health. The CCRCs-Entry Fee segment allows residents in the independent living apartment units to pay a one-time upfront entrance fee to use certain amenities and services. The Innovative Senior Care segment provides outpatient therapy, home health, and hospice services to residents of its communities and other senior living communities. The Management Services segment operates third party communities under the management agreements. As of December 31, 2012, it operated 76 retirement center communities with 14,528 units; 433 assisted living communities with 21,594 units; 27 rental CCRC communities with 6,748 units; 14 entry fee CCRC communities with 5,866 units; and 97 communities with 17,998 units for third parties. Brookdale Senior Living Inc. is based in Brentwood, Tennessee.
Advisors' Opinion:- [By John Kell]
Brookdale Senior Living Inc.(BKD) has agreed to merge with Emeritus Corp.(ESC) in a deal that values the operator of long-term, assisted-living facilities at about $1.4 billion, as the companies look to form a national senior-living-solutions company. Emeritus surged 34% to $28.75 premarket.
- [By Sean Williams]
One company with seemingly limitless upside potential today was senior housing operator Emeritus (NYSE: ESC ) , which gained 35.2% after agreeing to be purchased by Brookdale Senior Living (NYSE: BKD ) for $1.4 billion, excluding debt. Under the terms of the deal, Emeritus shareholders will receive 0.95 shares of Brookdale, and would effectively own 23% of the outstanding shares of the company once the merger is complete. Brookdale anticipates the deal being EPS neutral in 2014, and forecasts it adding $0.40 in EPS by the third year. The move certainly makes sense on paper, as cost synergies will help these two senior housing companies fight back against the expectation of declining Medicare reimbursement rates. However, over the long run, the Medicare reimbursement picture is still very cloudy, making Brookdale a riskier buy at the moment following today's announcement.
Top 10 Sliver Stocks To Invest In 2014: United Technologies Corporation(UTX)
United Technologies Corporation provides technology products and services to the building systems and aerospace industries worldwide. The company?s Otis segment designs, manufactures, sells, and installs passenger and freight elevators, escalators, and moving walkways, as well as provides maintenance and repair services. Its Carrier segment offers heating, ventilating, air conditioning, and refrigeration systems, controls, services, and energy-efficient products for residential, commercial, industrial, and transportation applications. The company?s UTC Fire and Security segment provides electronic security products comprising intruder alarms, and access control and video surveillance systems; fire safety products, such as specialty hazard detection and fixed suppression products, fire extinguishers, fire detection and life safety systems, and other firefighting equipment; systems integration, video surveillance, installation, maintenance, and inspection services; and mon itoring, response, and security personnel services. Its Pratt and Whitney segment supplies aircraft engines for the commercial, military, business jet, and general aviation markets; industrial gas turbines; geo thermal power systems; and space propulsion systems, as well as provides fleet management, maintenance, repair, and overhaul services. The company?s Hamilton Sundstrand segment supplies aerospace products, such as power generation, management and distribution, flight control, engine control, environmental control, auxiliary power units, and propeller systems; and industrial products, including air compressors, metering pumps, and fluid handling equipment under the Sullair, Sundyne, and Milton Roy names. Its Sikorsky segment manufactures military and commercial helicopters, as well as offers aftermarket helicopter and aircraft parts and services. United Technologies Corporation was founded in 1934 and is based in Hartford, Connecticut.
Advisors' Opinion:- [By Matt Thalman]
One of the Dow's biggest losers of the day was United Technologies (NYSE: UTX ) , which fell 2.16% this afternoon. The move came after news broke indicating that United Tech's Pratt & Whitney division and Rolls-Royce were abandoning their possible joint venture plan. The two companies had previously discussed the idea of joining forces to build the next generation engine that would be used in both Airbus aircraft and Boeing planes. The venture would have given the companies essentially a monopoly on the engine market for narrow-body planes, which is what the two organizations realized, and why they ultimately decided not to move forward with the plan.
- [By Katie Spence]
Major profits ahead
With a price tag of $52 billion, the KC tanker contract is one of the Pentagon's largest weapons initiatives. Further, some analysts estimate that with future parts and maintenance, the contract worth could climb to $100 billion. This is great news for Boeing, but it's also great news for its subcontractors on the project -- Honeywell International� (NYSE: HON ) is supplying the auxiliary power unit and cabin pressure control unit, Northrop Grumman (NYSE: NOC ) is supplying Large Aircraft Infrared Countermeasures, United Technologies' (NYSE: UTX ) subsidiary Pratt & Whitney is supplying the engines, Rockwell Collins� (NYSE: COL ) is supplying the integrated display system, and Raytheon�is supplying the digital radar-warning receiver. All in all, this is a major initiative for defense contractors, and good news for Boeing is good news for all.�
Top 10 Sliver Stocks To Invest In 2014: (LTUM)
Lithium Corporation, an exploration stage company, engages in the identification, acquisition, and exploration of metals and minerals with a focus on lithium mineralization in Nevada. It holds interests in Fish Lake Valley property that covers approximately 7,360 acres located in west central Nevada in northern Esmeralda County; Salt Wells property, which covers approximately 8,500 acres in Churchill County; and Cortez property that consists of approximately 4,960 acres located in Lander County, Nevada. The company was formerly known as Utalk Communications Inc. and changed its name to Lithium Corporation in September 2009. Lithium Corporation was founded in 2007 and is based in Reno, Nevada.
Advisors' Opinion:- [By CRWE]
Today, LTUM has shed (-19.80%) down -0.0079 at $.0320 with 33,100 shares in play thus far (ref. google finance Delayed: 11:18AM EDT June 26, 2013), but don�� let this get you down.
Location Based Technologies, Inc. previously reported it received FCC and IC certification for its versatile LBT-886 device. These certifications are necessary before devices can be sold to consumers throughout the US and Canada.
Lithium Corporation previously reported it has recently acquired a new Graphite (BC Sugar) prospect in the Shuswap area of British Columbia, in an under-explored area. In addition to the acquired claim, Lithco has also staked another four claims, to bring the total area to be explored by the Company to 3,405.77 acres (1,378.27 hectares). Although graphite has been identified locally in marbles, it has become apparent that graphite is also hosted here in quartz, biotite/mica gneisses, and also in calc-silicate gneisses. The host rocks at BC Sugar are similar to the host rocks in the area of the Crystal Graphite deposit 55 miles (90 kms) to the Southeast, where Lithium Corporation holds the Mt Heimdal block of claims.
Top 10 Sliver Stocks To Invest In 2014: Market Vectors Brazil Small-Cap ETF (BRF)
Market Vectors Brazil Small-Cap ETF (the Fund) seeks to replicate as closely as possible the price and yield performance of the Market Vectors Brazil Small-Cap Index (the Index). The Index is a rules-based, modified market capitalization-weighted, float-adjusted index consisting of publicly traded small-capitalization companies that are domiciled and primarily listed on an exchange in Brazil, or that generate at least 50% of their revenues in Brazil. The Index is the exclusive property of 4asset-management GmbH, which has contracted with Standard & Poor��, a division of The McGraw-Hill Companies, Inc. to maintain and calculate the Index. The Fund is passively managed and may not hold each Index component in the same weighting as the Index. The Fund�� investment advisor is Van Eck Associates Corporation. Advisors' Opinion:- [By Hilary Kramer]
Brasil Foods SA (BRF) is South America�� largest food processing company, involved in everything from meat and dairy products to pasta, frozen vegetables and soybean-related products. The company has been around since 1939, and Forbes ranked it 39th on its list of the world�� most innovative companies. It brings in about $13 billion in sales each year, and analysts are estimating that earnings will grow from 94 cents per share in 2012 to $1.94 for all of 2013, with additional growth to $2.78 in 2014.
- [By Jon C. Ogg]
Market Vectors Brazil Small-Cap ETF (NYSEArca: BRF) has performed closely with the larger ETF group, with a drop of almost 4% so far in 2014. By its name, you can assume it tracks small-cap stocks. It aims to track the Market Vectors Brazil Small-Cap Index. At $28.51, its 52-week trading range is $27.99 to $44.17.
Top 10 Sliver Stocks To Invest In 2014: Tractebel Energia SA (TBLE3)
Tractebel Energia SA (Tractebel Energia) is a Brazil-based company involved in the energy sector. The Company is engaged in the generation and sale of electric power generated by its assets or acquired through near and long-term agreements. In addition, it provides online customer services to its customers. Tractebel Energia operates power plants in the Brazilian states of Santa Catarina, Rio Grande do Sul, Parana, Sao Paulo, Mato Grosso do Sul, Mato Grosso, Goias, Ceara, Piaui, Minas Gerais, Tocantins and Maranhao. The Company generates energy through hydroelectric power plants, thermoelectric plants, small hydroelectric power plants, wind farms and biomass fired power plants. The Company is controlled by GDF SUEZ Energy Latin America Participacoes Ltda. Advisors' Opinion:- [By Patricia Lara]
The state-run water company�� market value rose to a record $11.1 billion at the end of last month, narrowing the gap to generator Tractebel Energia SA (TBLE3) to about $360.7 million, data compiled by Bloomberg show. That�� down from $1 billion at the end of last year and $3.89 billion at the start of 2012.
Top 10 Sliver Stocks To Invest In 2014: Oncolytics Biotech Inc (ONCY)
Oncolytics Biotech Inc. (Oncolytics), incorporated on April 2, 1998, is a development-stage company. The Company is focused on its research and development of REOLYSIN, which is its cancer therapeutic. REOLYSIN is developed from the reovirus. This virus has been demonstrated in tumour cells bearing an activated Ras pathway. Oncolytics is directing a clinical trial program with the focus of developing REOLYSIN as a human cancer therapeutic. The clinical program includes clinical trials, which it sponsors directly along with Third Party Clinical Trials. Third Party Clinical Trials are clinical trials that are being sponsored by other institutions. As of December 31, 2011, the United States National Cancer Institute (NCI), the University of Leeds and the Cancer Therapy & Research Center at the University of Texas Health Center in San Antonio (CTRC) were sponsoring part of its clinical trial program.
The Company�� clinical trial program has included human trials using REOLYSIN alone, and in combination with radiation and chemotherapy, and delivered via local administration and/or intravenous administration. Oncolytics uses contract toll manufacturers to produce REOLYSIN. On December 31, 2011, the Company had two wholly owned subsidiaries, Oncolytics Biotech (Barbados) Inc. (OBB) and Valens Pharma Ltd. Oncolytics Biotech (US) Inc. and Oncolytics Biotech (U.K.) are wholly owned subsidiaries of OBB.
Advisors' Opinion:- [By Sean Williams]
With this in mind, I feel it'd be prudent of biotech-savvy investors to give Oncolytics Biotech (NASDAQ: ONCY ) a closer look.
The big risks
I'm quite aware that there are a lot factors that'd raise a red flag with Oncolytics. Similar to Affymax, you could say that Oncolytics has put all of its eggs in one basket with its lead experimental drug, reolysin. According to Oncolytics' website, including its U.K., Canadian, and U.S. studies, reolysin as either a monotherapy or combination therapy is the basis for all 31 clinical trials! Obviously, if reolysin proves ineffective or unsafe, Oncolytics is going to be a world of hurt. - [By Maxx Chatsko]
T-VEC is not your traditional biologic drug. It is actually a bioengineered form of the herpes virus that, once injected into cancerous tumors, replicates, and produces an immune-stimulating protein that puts a bulls eye on cancer cells throughout the body. Despite its promise and intriguing mechanism of action, T-VEC is not in further development at Amgen. However, Oncolytics (NASDAQ: ONCY ) has shown promising results for its bioengineered form of reovirus called Reolysin. Initial phase 3 results showed that 86% of patients taking the drug had reduced tumor mass or growth after six weeks of treatment. �
- [By John Udovich]
The biotech sector along with small cap biotech stocks Cardiome Pharma Corp (NASDAQ: CRME), Oncolytics Biotech, Inc (NASDAQ: ONCY), Vital Therapies Inc (NASDAQ: VTL) and TNI BioTech (OTCMKTS: TNIB) have all been producing their share of news this week for investors and traders alike to trade on. Moreover and while some 42 ��ife sciences��companies have gone public raising about $3 billion from investors so far this year, there are a growing number of biotechs pulling the plug on upcoming IPOs who are citing market conditions. With that in mind, here is a look at important news from the biotech sector and small cap biotech stocks this week:
Top 10 Sliver Stocks To Invest In 2014: Cleveland BioLabs Inc.(CBLI)
Cleveland BioLabs, Inc., a biotechnology company, engages in the discovery, development, and commercialization of products for cancer treatment, and protection of normal tissues from radiation and other acute stresses. Its products include Protectan CBLB502, a radioprotectant molecule with multiple medical and defense applications for reducing injury from acute stresses, such as radiation and chemotherapy by mobilizing various natural cell protecting mechanisms, including inhibition of apoptosis, reduction of oxidative damage, and induction of factors that induce protection and regeneration of stem cells in bone marrow and the intestines; Protectan CBLB612, a modified lipopeptide mycoplasma that acts as a stimulator and mobilizer of hematopoietic stem cells to peripheral blood, providing hematopoietic recovery during chemotherapy and during donor preparation for bone marrow transplantation; and Curaxins, which are small molecules intended to destroy tumor cells by simultan eously targeting two regulators of apoptosis. The company has a strategic research partnership with Roswell Park Cancer Institute to develop its anticancer and radioprotectant drug candidates; a strategic partnership with ChemBridge Corporation to access a chemical library of 214,000 compounds; and a strategic alliance with The Cleveland Clinic Foundation (CCF). It also has a cooperative research and development agreement with the Uniformed Services University of the Health Sciences; the Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc.; and CCF to evaluate its radioprotective drug candidates and their effects on intracellular and extracellular signaling pathways. The company was founded in 2003 and is headquartered in Buffalo, New York.
Advisors' Opinion:- [By Lisa Levin]
Cleveland BioLabs (NASDAQ: CBLI) plummeted 32.65% to $0.7610 as the company reported that BARDA has terminated negotiations related to its proposal for further development of Entolimod.
- [By Lisa Levin]
Cleveland BioLabs (NASDAQ: CBLI) shares tumbled 34.67% to touch a new 52-week low of $0.74 as the company reported that BARDA has terminated negotiations related to its proposal for further development of Entolimod.
No comments:
Post a Comment